2019 American Transplant Congress
Clinical Outcomes of Living versus Deceased Donor Liver Transplantation for Primary Sclerosing Cholangitis: A Multicenter 15 Year Experience
*Purpose: MELD-based allocation is known to reduce access to deceased donor liver transplantation (DDLT) for patients with primary sclerosing cholangitis (PSC). Living donor liver transplantation(LDLT)…2019 American Transplant Congress
Significant Implications of Prior Transplantation on Treatment and Outcomes of Patients Suffering from Traumatic Brain Injury
The University of Toledo Medical Center, Toledo, OH
*Purpose: Recent events in the media and sporting industry highlight traumatic brain injury (TBI) as a major health concern, having implications in many areas of…2019 American Transplant Congress
Outcomes of Liver Transplantation for Mixed Hepatocellular-Cholangiocarcioma
1Columbia University Medical Center, New York, NY, 2Weill Cornell Medicine, New York, NY
*Purpose: Mixed hepatocholangiocarcinomas (HCC-CCA) are rare tumors with both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) differentiations. They are usually associated with a worse prognosis than…2019 American Transplant Congress
Impact of Coronary Artery Disease on Long-Term Mortality after Liver Transplantation
*Purpose: Cardiovascular disease (CVD) is an important cause of post liver transplantation (LT) mortality and is higher than age-and gender matched cohorts. This happens despite…2019 American Transplant Congress
Impact of Multidrug-Resistant Microbes of Donor Lower Respiratory Tract on Early Posttransplant Pneumonia in Bilateral Lung Transplant Recipients without Pretransplant Infection
*Purpose: Colonized microbes in lower respiratory tract (LRT) of deceased donor allograft can potentially cause early posttransplant pneumonia (EPTP) that leads to detrimental outcome in…2019 American Transplant Congress
Risk Factors for Post-Transplant Outcomes in Living and Deceased Donor Liver Transplantation. An Analysis of UNOS Registry
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: The Model for End-Stage Liver Disease (MELD) score has been used for predicting waitlist outcomes in patients with cirrhosis. However, the post-transplant prognostic value…2019 American Transplant Congress
Ex Vivo Resection And Autologous Liver Transplantation As Management Concept For Extensive Malignancy
*Purpose: Neuroblastomas are rare neural crest derived tumors which contribute disproportionally to childhood morbidity and mortality. Surgical resection remains standard treatment, however adequate resection is…2019 American Transplant Congress
Impact of Simultaneous Pancreas-Kidney Transplantation on Cardiovascular Risk in Type 1 Diabetic Patients
Servei de Nefrologia i Trasplantament Renal, Hospital Clínic de Barcelona, Barcelona, Spain
*Purpose: Cardiovascular disease is the main cause of death in patients with type 1 diabetes mellitus (DM1). Information available about the impact of simultaneous pancreas-kidney…2019 American Transplant Congress
Identification Of Pre-transplant Biomarkers Of Recipient Immune Dysfunction That Predict Recipient Risk Of Death Following Liver Transplant: The Immune Frailty Index
*Purpose: Cirrhosis-related immune dysfunction is well recognized and likely contributes to early mortality following liver transplant (LT) resulting from infections; however, few prior studies have…2019 American Transplant Congress
Profile of Invasive Fungal Disease after Kidney Transplantation in a Single Brazilian Center
Nephrology, Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
*Purpose: This study sought to describe the epidemiology of Invasive fungal disease at a brazilian kidney transplant center.*Methods: We retrospectively evaluated the diagnoses of invasive…
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 66
- Next Page »